Zhejiang Sunflower Great Health Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Zhejiang Sunflower Great Health.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Semiconductor earnings growth | 48.2% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Zhejiang Sunflower Great Health Co., Ltd.'s (SZSE:300111) 60% Share Price Surge Not Quite Adding Up
Oct 08Zhejiang Sunflower Great Health (SZSE:300111) Might Have The Makings Of A Multi-Bagger
Aug 05Some Shareholders Feeling Restless Over Zhejiang Sunflower Great Health Co., Ltd.'s (SZSE:300111) P/S Ratio
Jul 05Zhejiang Sunflower Great Health's (SZSE:300111) Promising Earnings May Rest On Soft Foundations
May 03Zhejiang Sunflower Great Health (SZSE:300111) Is Doing The Right Things To Multiply Its Share Price
Apr 17Zhejiang Sunflower Great Health Co., Ltd. (SZSE:300111) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected
Mar 08In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Zhejiang Sunflower Great Health has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
9/30/2024 | 330 | 1 | 315 | 77 | N/A |
6/30/2024 | 346 | 35 | 367 | 128 | N/A |
3/31/2024 | 361 | 35 | 52 | 59 | N/A |
12/31/2023 | 338 | 22 | -7 | 3 | N/A |
9/30/2023 | 357 | 38 | -283 | -26 | N/A |
6/30/2023 | 342 | -1 | -408 | -153 | N/A |
3/31/2023 | 336 | -7 | -106 | -65 | N/A |
1/1/2023 | 336 | -1 | -18 | 24 | N/A |
9/30/2022 | 340 | 37 | 1 | 54 | N/A |
6/30/2022 | 339 | 41 | 84 | 145 | N/A |
3/31/2022 | 307 | 41 | 114 | 132 | N/A |
1/1/2022 | 297 | 53 | 82 | 99 | N/A |
9/30/2021 | 256 | 34 | 24 | 51 | N/A |
6/30/2021 | 236 | 36 | -11 | 9 | N/A |
3/31/2021 | 268 | 52 | 73 | 99 | N/A |
12/31/2020 | 287 | 56 | 31 | 53 | N/A |
9/30/2020 | 380 | -36 | 45 | 61 | N/A |
6/30/2020 | 609 | -97 | 15 | 37 | N/A |
3/31/2020 | 760 | -97 | 28 | 48 | N/A |
12/31/2019 | 837 | -115 | 38 | 59 | N/A |
9/30/2019 | 835 | -932 | -205 | -185 | N/A |
6/30/2019 | 779 | -943 | 14 | 27 | N/A |
3/31/2019 | 855 | -1,094 | -24 | -3 | N/A |
12/31/2018 | 900 | -1,125 | 68 | 87 | N/A |
9/30/2018 | 1,288 | -238 | 509 | 541 | N/A |
6/30/2018 | 1,300 | -165 | N/A | 277 | N/A |
3/31/2018 | 1,530 | 11 | N/A | 358 | N/A |
12/31/2017 | 1,530 | 24 | N/A | 205 | N/A |
9/30/2017 | 1,448 | -6 | N/A | 241 | N/A |
6/30/2017 | 1,517 | -14 | N/A | 268 | N/A |
3/31/2017 | 1,437 | -18 | N/A | 272 | N/A |
12/31/2016 | 1,603 | 31 | N/A | 365 | N/A |
9/30/2016 | 1,893 | 109 | N/A | 240 | N/A |
6/30/2016 | 1,916 | 140 | N/A | 203 | N/A |
3/31/2016 | 1,956 | 145 | N/A | 227 | N/A |
12/31/2015 | 1,824 | 88 | N/A | 226 | N/A |
9/30/2015 | 1,831 | 112 | N/A | 229 | N/A |
6/30/2015 | 1,687 | 61 | N/A | 293 | N/A |
3/31/2015 | 1,554 | 21 | N/A | 96 | N/A |
12/31/2014 | 1,644 | 37 | N/A | 114 | N/A |
9/30/2014 | 1,189 | -37 | N/A | -12 | N/A |
6/30/2014 | 1,288 | -10 | N/A | 10 | N/A |
3/31/2014 | 1,184 | 12 | N/A | 76 | N/A |
12/31/2013 | 1,123 | 41 | N/A | 70 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 300111's forecast earnings growth is above the savings rate (2.8%).
Earnings vs Market: Insufficient data to determine if 300111's earnings are forecast to grow faster than the CN market
High Growth Earnings: Insufficient data to determine if 300111's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 300111's revenue is forecast to grow faster than the CN market.
High Growth Revenue: Insufficient data to determine if 300111's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 300111's Return on Equity is forecast to be high in 3 years time